Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Advanced Solid Tumors × Injections, Subcutaneous × 1 year × Clear all

Sponsor

Conditions

Breast Neoplasms 3 Multiple Myeloma 2 Squamous Cell Carcinoma of Head and Neck 1 Recurrent Metastatic Non-Squamous Non Small Cell Lung Cancer 1 Patient Preference 1 Inflammatory Breast Neoplasms 1 Colorectal Neoplasms 1 Carcinoma, Non-Small-Cell Lung 1 CD20-positive Hematological Malignancies 1 Bile Duct Neoplasms 1 Advanced Cancers 1

Interventions

Injections 16 Carboplatin 8 pembrolizumab 7 Bevacizumab 7 Leucovorin 6 Fluorouracil 6 Docetaxel 5 Pemetrexed 4 Paclitaxel 4 Oxaliplatin 4 trifluridine tipiracil drug combination 3 atezolizumab 3 Capecitabine 3 tislelizumab 2 spartalizumab 2 sotorasib 2 palbociclib 2 olaparib 2 fludarabine 2 Panitumumab 2 Irinotecan 2 HMPL-013 2 Fulvestrant 2 Etoposide 2 Drug Therapy 2 Cyclophosphamide 2 Cisplatin 2 Cetuximab 2 130-nm albumin-bound paclitaxel 2 zimberelimab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡